Inventor
MALHOTRA GEENA
IN77 patents
⚠️ This page may combine multiple inventors who share the name “MALHOTRA GEENA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CIPLA LTD
37 patentsUS9901585B2Feb 27, 2018
Combination of azelastine and fluticasone for nasal administration
CIPLA LTD12 citations93
USD646780SOct 11, 2011
Inhaler device
CIPLA LTD10 citations84
US8006695B2Aug 30, 2011
Inhaler
CIPLA LTD12 citations84
USD590057SApr 7, 2009
Inhaler
CIPLA LTD8 citations84
US7395821B2Jul 8, 2008
Multi-dose inhaler
CIPLA LTD13 citations84
US10301282B2May 28, 2019
Polymorphic form X of nilotinib dihydrochloride hydrate
CIPLA LTD6 citations81
US9913853B2Mar 13, 2018
Stabilized liquid fosaprepitant formulations
CIPLA LTD7 citations81
US10940274B2Mar 9, 2021
Nasal spray assembly
CIPLA LTD9 citations78
US10098890B2Oct 16, 2018
Stable carfilzomib formulations
CIPLA LTD7 citations78
USD563546SMar 4, 2008
Device for inhalation
CIPLA LTD7 citations74
US10912734B2Feb 9, 2021
Depot formulation
CIPLA LTD2 citations72
US11077124B2Aug 3, 2021
Pharmaceutical compositions
CIPLA LTD2 citations71
US10307432B2Jun 4, 2019
Stabilized liquid fosaprepitant formulations
CIPLA LTD2 citations70
US9446054B2Sep 20, 2016
Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids
CIPLA LTD2 citations63
US9259428B2Feb 16, 2016
Combination of azelastine and fluticasone for nasal administration
CIPLA LTD2 citations63
US8937057B2Jan 20, 2015
Combination of azelastine and mometasone for nasal administration
CIPLA LTD2 citations63
US8933060B2Jan 13, 2015
Combination of azelastine and ciclesonide for nasal administration
CIPLA LTD2 citations63
US11596597B2Mar 7, 2023
Depot formulation
CIPLA LTD0 citations62
US11478483B2Oct 25, 2022
Method of treating hypertension
CIPLA LTD0 citations62
US11224591B2Jan 18, 2022
Pharmaceutical compositions comprising rifaximin
CIPLA LTD0 citations62
US11207319B2Dec 28, 2021
Method for the treatment of bladder cancer
CIPLA LTD0 citations62
US11129836B2Sep 28, 2021
PAR-4 agonists for the treatment of cancer
CIPLA LTD0 citations62
US10709715B2Jul 14, 2020
Method of treating hypertension
CIPLA LTD1 citations62
US10391080B2Aug 27, 2019
Ketorolac for the treatment of cancer
CIPLA LTD1 citations62
US12472190B2Nov 18, 2025
Pharmaceutical compositions
CIPLA LTD0 citations60
US11612612B2Mar 28, 2023
Pharmaceutical compositions
CIPLA LTD0 citations60
US11234981B2Feb 1, 2022
Combination therapy for use in treating retroviral infections
CIPLA LTD1 citations60
US12090163B2Sep 17, 2024
Pharmaceutical compositions
CIPLA LTD1 citations58
US10933047B2Mar 2, 2021
Stabilized cabazitaxel formulations
CIPLA LTD0 citations57
US12324811B2Jun 10, 2025
Intranasal formulation
CIPLA LTD0 citations56
US12384784B2Aug 12, 2025
Polymorphs of Acalabrutinib, a Bruton's tyrosine kinase inhibitor
CIPLA LTD0 citations54
US7892483B2Feb 22, 2011
Sterilization process
CIPLA LTD3 citations54
US10765644B2Sep 8, 2020
Methods for the treatment of hepatitis C
CIPLA LTD0 citations52
US10149848B2Dec 11, 2018
Method for the treatment of bladder cancer
CIPLA LTD1 citations52
US10071062B2Sep 11, 2018
Methods for the treatment of hepatitis C
CIPLA LTD0 citations52
US10022377B2Jul 17, 2018
Method of treating hypertension
CIPLA LTD0 citations52
US10016377B2Jul 10, 2018
Treatment of hepatitis C using histone deacetylase inhibitors
CIPLA LTD0 citations52
LULLA AMAR
5 patentsUS8318709B2Nov 27, 2012
Combination of azelastine and mometasone for nasal administration
LULLA AMAR14 citations92
US8304405B2Nov 6, 2012
Combination of azelastine and ciclesonide for nasal administration
LULLA AMAR14 citations92
US8168620B2May 1, 2012
Combination of azelastine and steroids
LULLA AMAR19 citations92
US8163723B2Apr 24, 2012
Combination of azelastine and steroids
LULLA AMAR10 citations92
US8962601B2Feb 24, 2015
Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids
LULLA AMAR15 citations84
U & I PHARMACEUTICALS LTD
3 patentsUS6676965B1Jan 13, 2004
Enteric coated formulation for bisphosphonic acids and salts thereof
U & I PHARMACEUTICALS LTD45 citations96
US6962691B1Nov 8, 2005
Topical spray compositions
U & I PHARMACEUTICALS LTD133 citations95
US7011847B2Mar 14, 2006
Enteric coated formulation for bisphosphonic acids and salts thereof
U & I PHARMACEUTICALS LTD16 citations92
MALHOTRA GEENA
2 patentsCIPLA UK LTD
2 patentsBYRON FINE CHEMICALS INC
1 patentShowing the top 50 of 77 patents by PatentIndex Score.